Dow Up0.51% Nasdaq Up0.24%

Biogen Idec Inc. (BIIB)

303.55 4.45(1.49%) Nov 21, 4:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):2.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:371.24
Median Target:382.00
High Target:474.00
Low Target:262.00
No. of Brokers:21

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 22, 2014Robert W. BairdUpgradeNeutralOutperform
Oct 30, 2013FBR CapitalInitiated Mkt Perform
Dec 18, 2012Canaccord GenuityInitiated Hold
Oct 5, 2012OppenheimerDowngradeOutperformPerform
Sep 10, 2012UBSDowngradeBuyNeutral
Dec 9, 2011Barclays CapitalInitiated Overweight
Sep 9, 2011UBSUpgradeNeutralBuy
Aug 18, 2011OppenheimerUpgradePerformOutperform
Jun 21, 2011Deutsche BankUpgradeHoldBuy
Apr 15, 2011MP AdvisorsUpgradeMarket PerformOutperform

More Upgrades & Downgrades for BIIB

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0554

Data provided by Thomson/First Call

Currency in USD.